Login to Your Account



Gilead's Antiretroviral Emtriva Receives FDA Approval In HIV

By Aaron Lorenzo


Thursday, July 3, 2003
HIV patients gained another treatment option yesterday as the FDA signed off on Emtriva, a once-daily capsule for HIV from Gilead Sciences Inc. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription